CytomX Therapeutics, Inc. (CTMX)

Last Closing Price: 2.05 (2026-11-19)

Profit Margin (Quarterly)

Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues

CytomX Therapeutics, Inc. (CTMX) had Profit Margin of -1184.72% for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$1.69M
$-20.00M
--
$1.69M
$25.19M
$-23.50M
$3.56M
$-19.94M
$-19.94M
$-20.00M
$-20.00M
$-20.00M
$-20.00M
$-23.50M
$-24.45M
219.11M
219.11M
$-0.09
$-0.09
Balance Sheet Financials
$356.05M
$2.52M
$8.63M
$364.68M
$45.53M
--
$34.26M
$79.79M
$284.89M
$283.61M
$284.89M
218.00M
Cash Flow Statement Financials
$-26.97M
$-186.83M
$235.09M
$14.19M
$35.49M
$21.30M
$10.13M
--
--
Fundamental Metrics & Ratios
7.82
--
--
--
--
100.00%
-1392.30%
-1392.30%
--
-1181.10%
Profit Margin
-1184.72%
$-27.26M
--
--
--
0.00
--
3.37
26.71
-7.02%
-7.05%
-5.48%
-7.02%
$1.31
$-0.12
$-0.12